Consultation - ANZTPA
Consultation programme released for the establishment of the Australia New Zealand Therapeutic Products Authority
27 March 2006
Details of the consultation process being undertaken as part of the establishment of the joint Australia New Zealand Therapeutics Products Authority are now available.
The Authority will replace Australia’s Therapeutic Goods Administration (TGA) and the New Zealand Medicines and Medical Devices Safety Authority (Medsafe). Its role will be to regulate therapeutic products such as prescription and over-the-counter medicines, complementary medicines, medical devices and blood products in both countries.
Consulting widely with industry and other stakeholders is a key component in the development of the new Authority.
There will be three phases of public consultation in which submissions will be sought on the proposed regulatory scheme. These phases will begin in late May 2006, September 2006 and March 2007.
Separate but aligned Bills for Australia and New Zealand will be ready for the formal Parliamentary processes towards the middle of the year.
Further information about the consultation timeline is available on the Authority's website: http://www.anztpa.org